Active Shortage

APO-RAMIPRIL

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-RAMIPRIL in Canada?

Yes. APO-RAMIPRIL 2.5MG has an active shortage reported to Health Canada (last updated November 5, 2026).

Why is APO-RAMIPRIL not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-RAMIPRIL be available again?

The estimated resolution date (November 13, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file6 products

Affected strength2.5MG

Report last updated2026-11-05

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

MAR-RAMIPRIL

MARCAN PHARMACEUTICALS INC

2.5MG · DIN 02420465

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

AURO-RAMIPRIL

AURO PHARMA INC

2.5MG · DIN 02387395

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

PRO-RAMIPRIL - 2.5

PRO DOC LIMITEE

2.5MG · DIN 02310066

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

JAMP RAMIPRIL

JAMP PHARMA CORPORATION

2.5MG · DIN 02331128

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

ALTACE

BAUSCH HEALTH, CANADA INC.

1.25MG · DIN 02221829

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

TARO-RAMIPRIL

SUN PHARMA CANADA INC

1.25MG · DIN 02310503

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2026-11-13

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02251531

Strength

2.5MG

Dosage Form

CAPSULE

Route

ORAL

Active Ingredient

RAMIPRIL

Tier

Unrated

Last Updated

2026-11-05

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

APO-RAMIPRIL has 4 shortage/discontinuation reports on file — this is one of them.

2026-11-05

Active Shortage

Disruption of the manufacture of the drug.

2026-10-27

Resolved

Disruption of the manufacture of the drug.

2026-07-03

Resolved

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244